Oncothyreon (ONTY) Misses Primary Endpoint in L-BLP25 Phase 3
Go back to Oncothyreon (ONTY) Misses Primary Endpoint in L-BLP25 Phase 3| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.84 +0.04 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $1.37 | |||
| Open | $0.80 | 52 Week Low | $0.24 | |||
| Day High | $0.85 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 544,156 | |||||
| ONCOTHYREON (NASDAQ: ONTY) | Delayed: 1.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $4.11 | |||
| Open | $0.01 | 52 Week Low | $0.90 | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $-0.93 | |||
| Volume | 824,689 | |||||
